Financials
- Market Capitalization 539.57 M
- Employee 1 315
- Founded 2011
- CEO Ming Hsieh
- Website www.fulgentgenetics.com
- Headquarter Delaware, United States
- FIGI BBG00DR7LTG2
- Industry Diagnostic et Recherche
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-13.36
ratio cours/chiffre d'affaires
2.51
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2438 | CSTL Castle Biosciences, Inc. - Common stock | 33.50 USD | -2.22% | +1.45% | +20.37% | +36.10% | 1.02 B USD | ||
| 2530 | ACRS Aclaris Therapeutics, Inc. - Common Stock | 6.01 USD | -2.44% | -5.35% | +15.80% | +209.79% | 884.67 M USD | ||
| 3015 | PRE Prenetics Global Limited - Class A Ordinary Share | 25.76 USD | -1.87% | +34.66% | +32.44% | +226.08% | 434.68 M USD | ||
| 3314 | MYGN Myriad Genetics, Inc. - Common Stock | 3.16 USD | -0.63% | -1.25% | +10.49% | -61.79% | 302.25 M USD |